Literature DB >> 19682845

Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients.

Mehmet Turan Inal1, Dilek Memiş, Beyhan Karamanlioglu, Necdet Sut.   

Abstract

BACKGROUND: Hypovolemia is a common clinical entity in critical patients, and adequate volume replacement therapy seems to be essential for maintaining tissue perfusion. However, it is still uncertain which solution is most appropriate for fluid resuscitation.
OBJECTIVE: The aim of this study was to investigate the effects of fluid resuscitation with 3.5% polygeline versus 6% hydroxyethyl starch solutions on hemodynamic functions and liver functions assessed with a noninvasive liver function monitoring system (LIMON) in hypovolemic patients.
DESIGN: This study is a prospective randomized clinical trial. MEASUREMENTS AND
RESULTS: Thirty hypovolemic patients (intrathoracic blood volume index, <850 mL/m(2)) were randomized into hydroxyethyl starch (mean molecular weight, 130,000 Da) and polygeline (mean molecular weight, 30,000 Da) groups (15 patients each). Indocyanine green plasma disappearance elimination (ICG-PDR) were conducted concurrently using LIMON. A dose of 0.3 mg/kg ICG was given through a cubital fossa vein as a bolus. For fluid resuscitation, 500 mL of colloid was given to the patients. Repeated hemodynamic and ICG-PDR measurements were done at baseline, after infusion, and then at 30 minutes after infusion.
RESULTS: Intrathoracic blood volume index and systolic, diastolic, and mean blood pressures increased significantly after infusion and remained elevated for 30 minutes after infusion, but there was no significant difference between the 2 groups. Indocyanine green plasma disappearance elimination values were similar in both groups with no significant difference between the two.
CONCLUSION: Increasing intrathoracic blood volume index and hemodynamic variables by fluid loading is not associated with a significant change in ICG-PDR. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682845     DOI: 10.1016/j.jcrc.2009.06.013

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  6 in total

Review 1.  Colloid solutions for fluid resuscitation.

Authors:  Frances Bunn; Daksha Trivedi
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 2.  Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.

Authors:  David J Gattas; Arina Dan; John Myburgh; Laurent Billot; Serigne Lo; Simon Finfer
Journal:  Intensive Care Med       Date:  2013-02-14       Impact factor: 17.440

3.  Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.

Authors:  Bin He; Bo Xu; Xiaoxing Xu; Lixia Li; Rongrong Ren; Zhiyu Chen; Jian Xiao; Yingwei Wang; Bin Xu
Journal:  Crit Care       Date:  2015-03-19       Impact factor: 9.097

Review 4.  Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in Germany.

Authors:  Gernot Marx; Achim W Schindler; Christoph Mosch; Joerg Albers; Michael Bauer; Irmela Gnass; Carsten Hobohm; Uwe Janssens; Stefan Kluge; Peter Kranke; Tobias Maurer; Waltraut Merz; Edmund Neugebauer; Michael Quintel; Norbert Senninger; Hans-Joachim Trampisch; Christian Waydhas; Rene Wildenauer; Kai Zacharowski; Michaela Eikermann
Journal:  Eur J Anaesthesiol       Date:  2016-07       Impact factor: 4.330

5.  Polygeline in hypovolemia due to traumatic injury: Results of an open label study in Indian population.

Authors:  Ajai Singh; Sabir Ali
Journal:  Int J Crit Illn Inj Sci       Date:  2016 Jan-Mar

6.  Fluid resuscitation in critically ill patients: a systematic review and network meta-analysis.

Authors:  Chao Liu; Zhi Mao; Pan Hu; Xin Hu; Hongjun Kang; Jie Hu; Zhifang Yang; Penglin Ma; Feihu Zhou
Journal:  Ther Clin Risk Manag       Date:  2018-09-12       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.